EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Novel heterozygous OPA3 variant in a family with congenital cataracts, sensorineural hearing loss and neuropathy, without optic atrophy and comparison of pathogenic and population variants

Monica Penon-Portmann, Kendyl Naugle, Frank Brodie, Julie Schallhorn, Paul Griggs, Joyce So

American Journal of Medical Genetics Part A · 2025

DOI: 10.1002/ajmg.a.63846 ↗

Kurz gefasst

Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von Monica Penon-Portmann und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of California, San Francisco, San Francisco, California, USA. Hauptthemen laut MEDLINE: Cataract, Hearing Loss, Sensorineural, Heterozygote. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heterozygous mutations in the OPA3 gene are associated with autosomal dominant optic atrophy‐3 (OPA3), whereas biallelic mutations cause autosomal recessive 3‐methylglutaconic aciduria type III. To date, all cases with pathogenic variants in the gene OPA3 have presented with optic atrophy. We report a large family with congenital cataracts, hearing loss and neuropathy, with a likely pathogenic novel missense variant in OPA3 , c.30G>C; p.(Lys10Asn) that segregates with disease in the family pedigree. The family's clinical presentation has significant phenotypic overlap with previously reported cases of OPA3, except for a notable lack of optic atrophy. The analysis of all known disease‐associated variants in OPA3 revealed an enrichment in missense variants in patients with OPA3 phenotype compared with loss‐of‐function variants, which are more likely to be observed in individuals with 3‐methylglutaconic aciduria type III, supporting different mechanisms of disease. This case broadens the clinical and genetic spectrum associated with OPA3 mutations and highlights that optic atrophy is not an obligate feature of OPA3 ‐related disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CataractHearing Loss, SensorineuralHeterozygoteAdultFemaleHumansMaleGTP PhosphohydrolasesMutationMutation, MissenseOptic AtrophyPedigreePhenotypeAgedProteins

Stichwörter der Autor:innen

OPA3congenital cataractsmitochondrialneuropathyoptic atrophysensorineural hearing loss

Substanzen

GTP PhosphohydrolasesOPA3 protein, humanProteins

Autor:innen und Institutionen

  • University of California, San Francisco, San Francisco, California, USA.
  • University of Washington, Seattle, Washington, USA.
  • University of California, San Diego, La Jolla, California, USA.
  • Northwest Eye Surgeons, Seattle, Washington, USA.

Zitieren

APA

Penon-Portmann, M., Naugle, K., Brodie, F., Schallhorn, J., Griggs, P., & So, J. (2025). Novel heterozygous OPA3 variant in a family with congenital cataracts, sensorineural hearing loss and neuropathy, without optic atrophy and comparison of pathogenic and population variants. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63846

Vancouver

Penon-Portmann M, Naugle K, Brodie F, Schallhorn J, Griggs P, So J. Novel heterozygous OPA3 variant in a family with congenital cataracts, sensorineural hearing loss and neuropathy, without optic atrophy and comparison of pathogenic and population variants. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmg.a.63846

BibTeX
@article{PenonPortmann2025,
  author = {Penon-Portmann, Monica and Naugle, Kendyl and Brodie, Frank and Schallhorn, Julie and Griggs, Paul and So, Joyce},
  title = {Novel heterozygous OPA3 variant in a family with congenital cataracts, sensorineural hearing loss and neuropathy, without optic atrophy and comparison of pathogenic and population variants},
  journal = {American Journal of Medical Genetics Part A},
  year = {2025},
  doi = {10.1002/ajmg.a.63846}
}
Kostenlos starten →